During the past decade, East Tennessee Heart Consultants conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 3 clinical trials were completed, i.e. on average, 300% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "East Tennessee Heart Consultants" are "Anemia" (1 trials), "Bleeding Disorder" (1 trials), "Coagulation Disorder" (1 trials), "Coronary Artery Disease" (1 trials) and "Femoral Artery Occlusion" (1 trials). Many other conditions were trialed in "East Tennessee Heart Consultants" in a lesser frequency.

Most popular intervention types in "East Tennessee Heart Consultants" are "Device" (3 trials), "Drug" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "DAPT (aspirin and/or P2Y12 receptor inhibitor)" (1 trials), "Lutonix Drug Coated Balloon" (1 trials), "Moxy Drug Coated Balloon" (1 trials), "Standard Uncoated Angioplasty Balloon" (1 trials) and "XIENCE" (1 trials). Other intervention names were less common.

The vast majority of trials in "East Tennessee Heart Consultants" are 3 trials for "All" genders.

Currently, there are NaN active trials in "East Tennessee Heart Consultants". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in East Tennessee Heart Consultants, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in East Tennessee Heart Consultants, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".